Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eli Lilly Japan Helps Students Through Emotional Disorder Educational Programs

This article was originally published in PharmAsia News

Executive Summary

Eli Lilly Japan, along with other companies, has helped the Japanese nonprofit organization Association of Corporations and Education develop an educational program on emotional disorders targeting junior high and senior high school students. The development of the program also received advice and input from psychiatrists and patients. Pilot classes of the program were conducted at the end of November. Since then, the program has received accolades from experts in the field. Professor Mizuno of Toho University, a psychiatrist, states that from the point of early discovery and early treatment, teaching the program to junior and high school students who are prone to develop emotional disorders will be useful. The final compilation of materials for the program, including PowerPoint slides, DVD videos, teacher's manuals and videos of pilot classes, is scheduled to be completed by the middle of January. (Click here for more

You may also be interested in...

Warning Letter Roundup & Recap – 1 December 2020

In the only device-related warning letter released by the US FDA this week, Avazo Healthcare was selling two COVID-19 antigen tests without approval, clearance or authorization from the agency.

On-Site Inspections Of US Device Makers Plummet 93% As FDA Scrambles For Virtual Solutions

A sharp decline in the number of in-person facility inspections has forced the FDA to consider creative techniques for remotely evaluating manufacturer compliance during the COVID-19 pandemic. This and other stories topped our list of most-read Medtech Insight articles in November.

EU Health Ministers To Deliberate Over Commission’s Pharma Strategy

A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts